MedTrace Logo

Prebiotic Intervention for Autism Spectrum Disorders

NCT02720900 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2018-02-15

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a prebiotic (BGOS) on gut microbiota and metabolites in children with autism spectrum disorders.

Conditions

Interventions

DIETARY_SUPPLEMENT

B-GOS

1.8 g/day for 6 weeks

DIETARY_SUPPLEMENT

Maltodextrin

1.8 g/day for 6 weeks

Sponsors & Collaborators

  • University of Reading

    collaborator OTHER

  • Clasado Limited

    lead INDUSTRY

Principal Investigators

  • Jelena Vulevic, phd · Clasado Research Services

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-09-30
Completion
2017-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720900 on ClinicalTrials.gov